A diVIsive Shuffling Approach (VIStA) for gene expression analysis to identify subtypes in Chronic Obstructive Pulmonary Disease

BMC Systems Biology

Volumn 8, Issue 2, 2014, Pages

  Menche, Jörg ^a,b,c   Sharma, Amitabh ^a,b   Cho, Michael H ^d   Mayer, Ruth J ^e   Rennard, Stephen I ^f   Celli, Bartolome ^g   Miller, Bruce E ^e   Locantore, Nick ^e   Tal Singer, Ruth ^e   Ghosh, Soumitra ^e   Larminie, Chris ^h   Bradley, Glyn ^h   Riley, John H ^h   Agusti, Alvar ^i,k   Silverman, Edwin K ^d   Barabási, Albert László ^a,b,c,g,j  

^a NORTHEASTERN UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^d HARVARD MEDICAL SCHOOL   (United States)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h GLAXOSMITHKLINE   (United Kingdom)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j CENTRAL EUROPEAN UNIVERSITY   (Hungary)

^k INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

Chronic Bronchitis; COPD; Emphysema; Gene expression analysis; Subtyping

Indexed keywords

AGED; BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; METABOLISM; MOLECULARLY TARGETED THERAPY; OBSERVATIONAL STUDY; PATHOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

AGED; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MOLECULAR TARGETED THERAPY; OBSERVATIONAL STUDY AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 84907371840     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-8-S2-S8     Document Type: Article

References (18)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. American journal of respiratory and critical care medicine. 2013, 187 (4): 347-65. 10.1164/rccm.201204-0596PP.
2. Bhattacharya S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, Silverman EK, Reilly JJ, Mariani TJ: Molecular biomarkers for quantitative and discrete copd phenotypes. American journal of respiratory cell and molecular biology. 2009, 40 (3): 359-67. 10.1165/rcmb.2008-0114OC.
3. Singh D, Fox SM, Tal-Singer R, Plumb J, Bates S, Broad P, Riley JH, Celli B: Induced sputum genes associated with spirometric and radiological disease severity in copd ex-smokers. Thorax. 2011, 66 (6): 489-95. 10.1136/thx.2010.153767.
4. Pierrou S, Broberg P, O'Donnell RA, Pawlowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Moller S, Bergstrand H, Koopmann W, Wieslander E, Stromstedt PE, Holgate ST, Davies DE, Lund J, Djukanovic R: Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2007, 175 (6): 577-86. 10.1164/rccm.200607-931OC.
5. DeMeo D, Mariani T, Lange C, Lake S, Litonjua A, Celedon J, Reilly J, Chapman HA, Sparrow D, Spira A, Beane J, Pinto-Plata V, Speizer FE, Shapiro S, Weiss ST, Silverman EK: The serpine2 gene is associated with chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society. 2006, 3 (6): 502-10.1513/pats.200603-070MS.
6. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, Celli B, Brody JS: Gene expression profiling of human lung tissue from smokers with severe emphysema. American journal of respiratory cell and molecular biology. 2004, 31 (6): 601-10. 10.1165/rcmb.2004-0273OC.
7. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J: Characterisation of copd heterogeneity in the eclipse cohort. Respiratory research. 2010, 11: 122-
8. Agusti A, Sobradillo P, Celli B: Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and p4 medicine. American journal of respiratory and critical care medicine. 2011, 183 (9): 1129-37. 10.1164/rccm.201009-1414PP.
9. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R: Evaluation of copd longitudinally to identify predictive surrogate end-points (eclipse). The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2008, 31 (4): 869-73. 10.1183/09031936.00111707.
10. Barabasi AL, Gulbahce N, Loscalzo J: Network medicine: a network-based approach to human disease. Nature reviews Genetics. 2011, 12 (1): 56-68. 10.1038/nrg2918.
11. Coxson HO, Dirksen A, Edwards LD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Crim C, Duvoix A, Fauerbach PN, Lomas DA, MacNee W, Mayer RJ, Miller BE, Müller NL, Rennard SI, Silverman EK, Tal-Singer R, Wouters EF, Vestbo J: The presence and progression of emphysema in copd as determined by ct scanning and biomarker expression: a prospective analysis from the eclipse study. The Lancet Respiratory Medicine. 2013, 1 (2): 129-136. 10.1016/S2213-2600(13)70006-7.
12. Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B: Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012, 7 (5): 37483-10.1371/journal.pone.0037483.
13. Larsson O, Wahlestedt C, Timmons JA: Considerations when using the significance analysis of microarrays (sam) algorithm. BMC bioinformatics. 2005, 6: 129-10.1186/1471-2105-6-129.
14. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS. 2005, 102 (43): 15545-15550. 10.1073/pnas.0506580102.
15. Luo J, Chen YJ, Narsavage GL, Ducatman A: Predictors of survival in patients with non-small cell lung cancer. Oncology nursing forum. 2012, 39 (6): 609-16. 10.1188/12.ONF.609-616.
16. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM: Use of a cdna microarray to analyse gene expression patterns in human cancer. Nature genetics. 1996, 14 (4): 457-60.
17. Wellmann A, Thieblemont C, Pittaluga S, Sakai A, Jaffe ES, Siebert P, Raffeld M: Detection of differentially expressed genes in lymphomas using cdna arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood. 2000, 96 (2): 398-404.
18. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR: Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes. 2002, 51 (4): 1093-101. 10.2337/diabetes.51.4.1093.